Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome).

Wong HK, Mishra A, Hake T, Porcu P.

Br J Haematol. 2011 Oct;155(2):150-66. doi: 10.1111/j.1365-2141.2011.08852.x. Epub 2011 Aug 25. Review.

2.

European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.

Trautinger F, Eder J, Assaf C, Bagot M, Cozzio A, Dummer R, Gniadecki R, Klemke CD, Ortiz-Romero PL, Papadavid E, Pimpinelli N, Quaglino P, Ranki A, Scarisbrick J, Stadler R, Väkevä L, Vermeer MH, Whittaker S, Willemze R, Knobler R.

Eur J Cancer. 2017 May;77:57-74. doi: 10.1016/j.ejca.2017.02.027. Epub 2017 Mar 31. Review.

3.

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.

Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C.

J Am Acad Dermatol. 2014 Feb;70(2):205.e1-16; quiz 221-2. doi: 10.1016/j.jaad.2013.07.049. Review.

PMID:
24438969
4.
5.

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.

Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C.

J Am Acad Dermatol. 2014 Feb;70(2):223.e1-17; quiz 240-2. doi: 10.1016/j.jaad.2013.08.033. Review.

PMID:
24438970
6.

Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.

Edelson RL.

J Am Acad Dermatol. 1980 Feb;2(2):89-106. Review.

PMID:
6988470
7.

Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome.

Berg S, Villasenor-Park J, Haun P, Kim EJ.

Curr Hematol Malig Rep. 2017 Jun;12(3):234-243. doi: 10.1007/s11899-017-0387-9. Review.

PMID:
28540671
8.

Mycosis fungoides and the Sézary syndrome: a review of pathogenesis, diagnosis, and therapy.

Kuzel TM, Roenigk HH Jr, Rosen ST.

J Clin Oncol. 1991 Jul;9(7):1298-313. Review.

PMID:
2045869
9.

A new nail in the CTCL coffin.

Lessin SR.

J Invest Dermatol. 2006 Nov;126(11):2368-9.

10.

Immunopathogenesis of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma).

Wong HK.

G Ital Dermatol Venereol. 2008 Dec;143(6):375-83. Review.

PMID:
19169210
11.

Cutaneous T-cell lymphoma: a review.

Winkler CF, Bunn PA Jr.

Crit Rev Oncol Hematol. 1983;1(1):49-92. Review.

PMID:
6083835
12.

Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents.

Devata S, Wilcox RA.

Am J Clin Dermatol. 2016 Jun;17(3):225-37. doi: 10.1007/s40257-016-0177-5. Review.

PMID:
26923912
13.

Mycosis fungoides and Sezary syndrome.

Diamandidou E, Cohen PR, Kurzrock R.

Blood. 1996 Oct 1;88(7):2385-409. Review. No abstract available.

14.

[Current pathogenetic aspects of Sézary syndrome and mycosis fungoides].

Dummer R, Willers J, Döbbeling U, Burg G.

Hautarzt. 2001 Mar;52(3):189-92. German.

PMID:
11284062
15.

The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.

Papadavid E, Economidou J, Psarra A, Kapsimali V, Mantzana V, Antoniou C, Limas K, Stratigos A, Stavrianeas N, Avgerinou G, Katsambas A.

Br J Dermatol. 2003 Apr;148(4):709-18.

PMID:
12752128
17.

Cutaneous T cell lymphoma-mycosis fungoides and Sezary syndrome: an update.

Parker SR, Bethaney JV.

G Ital Dermatol Venereol. 2009 Aug;144(4):467-85.

PMID:
19755952
18.

Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC).

Olsen EA, Rook AH, Zic J, Kim Y, Porcu P, Querfeld C, Wood G, Demierre MF, Pittelkow M, Wilson LD, Pinter-Brown L, Advani R, Parker S, Kim EJ, Junkins-Hopkins JM, Foss F, Cacchio P, Duvic M.

J Am Acad Dermatol. 2011 Feb;64(2):352-404. doi: 10.1016/j.jaad.2010.08.037. Epub 2010 Dec 9. Review.

PMID:
21145619
19.

Th1 response and cytotoxicity genes are down-regulated in cutaneous T-cell lymphoma.

Hahtola S, Tuomela S, Elo L, Häkkinen T, Karenko L, Nedoszytko B, Heikkilä H, Saarialho-Kere U, Roszkiewicz J, Aittokallio T, Lahesmaa R, Ranki A.

Clin Cancer Res. 2006 Aug 15;12(16):4812-21.

20.

Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.

Wilcox RA.

Am J Hematol. 2016 Jan;91(1):151-65. doi: 10.1002/ajh.24233. Epub 2015 Nov 26. Review.

Supplemental Content

Support Center